Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($1.23) EPS for the quarter, topping analysts’ consensus estimates of ($2.01) by $0.78, Zacks reports.
Neuphoria Therapeutics Inc. – Common Stock Price Performance
Shares of NEUP traded up $0.20 during midday trading on Friday, hitting $4.80. The stock had a trading volume of 49,914 shares, compared to its average volume of 1,079,359. Neuphoria Therapeutics Inc. – Common Stock has a 1 year low of $2.12 and a 1 year high of $15.96.
Analyst Ratings Changes
Separately, HC Wainwright boosted their target price on shares of Neuphoria Therapeutics Inc. – Common Stock from $8.00 to $21.00 and gave the stock a “buy” rating in a report on Tuesday, February 4th.
About Neuphoria Therapeutics Inc. – Common Stock
Neuphoria Therapeutics, Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
Read More
- Five stocks we like better than Neuphoria Therapeutics Inc. – Common Stock
- Stock Splits, Do They Really Impact Investors?
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- P/E Ratio Calculation: How to Assess Stocks
- Up 50% in January, Twilio’s Pullback is the Time to Buy
- Best Stocks Under $10.00
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Neuphoria Therapeutics Inc. - Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuphoria Therapeutics Inc. - Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
